Neurology News Network: Notable FDA Approvals From 2025 | NeurologyLive

Thanks for watching. REFERENCES 1. FDA Approves Genentech’s TNKase® in Acute Ischemic Stroke in Adults. News release. Genentech. March 3, 2025.